A carregar...
Evaluation of quantitative modeling methods in whole-body, dynamic [(11)C]-erlotinib PET
Background: [(11)C]-Erlotinib is a radiolabeled analogue of a tyrosine kinase inhibitor used to treat non-small cell lung cancer (NSCLC) which expresses specific kinase domain mutations of the epidermal growth factor receptor (EGFR). In this study, 10 subjects with NSCLC and assorted EGFR mutation s...
Na minha lista:
| Publicado no: | Am J Nucl Med Mol Imaging |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
e-Century Publishing Corporation
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8165727/ https://ncbi.nlm.nih.gov/pubmed/34079641 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|